CLMT vs HUM · rev $4.14B vs P/E 39, rev $129.66B
Calumet Specialty Products Partners (CLMT) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
Calumet Specialty Products Partners (CLMT) is a specialty chemicals company listed on NASDAQ.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Latest reported CLMT revenue for 2025-12-31 was $4.14B. Net income was -$33.8M. Revenue was down 1.2% from 2024-12-31 to 2025-12-31. CLMT currently screens at market cap $2.89B.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
CLMT currently screens at market cap $2.89B. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the CLMT and HUM stock pages for the full models.
Not investment advice.